TD Cowen Reiterates Buy on NVIDIA, $140 Price Target

Apr 16, 2025 Analyst: Joshua Buchalter 1 min read Reproduced verbatim
Rating
Buy
Price target
$140
Implied upside
+25%
vs $112.20 prior close
TD Cowen and NVIDIA logos

TD Cowen analyst Joshua Buchalter reiterated a Buy rating and $140 price target on NVIDIA (NASDAQ: NVDA).

“NVIDIA disclosed the China-focused H20 is now subject to license requirements, resulting in up to $5.5B of inventory and other charges in the forthcoming AprQ.

While seemingly reigniting a near-term overhang for the stock, we note that Blackwell and the overall environment for sustainable AI demand remain the predominant driver of narrative and fundamentals.

Reiterate Thesis: NVIDIA Is The AI Leader: While we acknowledge near-term headwinds for NVIDIA (and peers alike) related to sales into China, we remain confident that NVIDIA is the leader in accelerated computing.

We believe the CPU/GPU/DPU combination of Grace/ Blackwell (eventually to Vera/Rubin) systems positions the company to sustain strong Datacenter growth in the coming years irregardless of any potential China-related issues longer-term.”

Disclaimer
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.

Tracking this call

Since this note+105% NVDA $112.20 → $230.48 (Oct 9) · target reached

Firm track recordTD Cowen: 71% of its 7 targets at least a year old were reached within 12 months (#9 of 14 firms); on NVIDIA, 2 of 2. Accuracy ranking →

Share
Share on
Price Target is an archive of Wall Street analyst research, published for informational purposes only. Nothing on this site is investment advice, a recommendation, or an offer to buy or sell any security. Analyst ratings and price targets are the opinions of the issuing firms, not of Price Target. Always do your own research or consult a licensed financial adviser.